New Delhi: The Oxford University and AstraZeneca vaccine study was recently stopped because of a patient’s poor health. However, it is now reported that Astrazeneca has resumed its trial of the corona vaccine in the UK. According to the company, the vaccine study has restarted after being approved by the UK Medical Board. Significantly, the vaccine trial was canceled first in the UK and then worldwide after the health of a volunteer in the UK deteriorated.
Regarding the vaccine, a recent statement was made that the company stopped the vaccine study on September 6 after a patient developed a side effect and asked the independent committee to investigate. Now that investigation is complete and the company has received approval to restart the process.
Also Read – Good News: Corona Medicine Made In India? Successful vaccine test on animals
The regulator says side effects are normal in one or two patients. For information, let us know that the Serum Institute of India is also testing this vaccine in India.
On Thursday, the Serum Institute of India issued a statement saying, “We are reviewing the situation and postponing the India process for the moment.” Serum is the largest vaccine company in the world by volume.